Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

NIH designs recombinant oncolytic immunotoxins that may be given at high doses

Aug. 9, 2012

New cancer vaccines designed by Oncbiomune

Aug. 8, 2012

Ono kicks off first-in-human study of peptide-cocktail vaccine

Aug. 6, 2012

Three-peptide vaccine for advanced esophageal cancer shows promise in phase I-II trials

Aug. 3, 2012

FDA clears IND application for ImmunoCellular Therapeutics cancer vaccine

July 26, 2012

Cytomedix collaborates with Duke University on brain cancer study

July 20, 2012

Phase I/II Actimab-A trial advances

July 20, 2012

New S100-A4-neutralizing antibody is a potential therapy and biomarker for cancer

July 19, 2012

OncoMed commences dosing in phase I trial of anticancer stem cell therapeutic

July 13, 2012

Overall response rate over 80% seen in elotuzumab trial

July 13, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...